Similarly, tirzepatide dose escalation from 5 mg to 7.5 mg, 10 mg, or even 15 mg can break through plateaus
The SELECT trial showed a 20% reduction in major adverse cardiovascular events in people with obesity and established cardiovascular disease (Lincoff et al., 2023)
Shifting Clinical Conversations We know that worry about drug testing and lab surprises is exhausting
Rather than further investigating the nearly 20,000 adverse events reported to the FDA, Novo Nordisk pumped billions into advertising and celebrity endorsers speaking out on the weight loss benefits, producing billions of dollars in revenue while users continue to report new digestive illnesses
DVT and NAION are serious conditions, and people who are diagnosed with these conditions due to their Ozempic use deserve to fight for compensation that is equivalent to their injuries